Annual Reviews tagline graphic
  Hello. Sign in to get personalized recommendations. New user? Register now.
 
Home Order Browse Search Profile Help Contact Us
Abstract
Annual Review of Immunology
Vol. 20: 29-53 (Volume publication date April 2002)
(doi:10.1146/annurev.immunol.20.091101.091806)
THE B7 FAMILY OF LIGANDS AND ITS RECEPTORS: New Pathways for Costimulation and Inhibition of Immune Responses

Beatriz M. Carreno and Mary Collins
Genetics Institute/Wyeth Research, 87 Cambridge Park Drive, Cambridge, Massachusetts 02140; e-mail:

Abstract T cell activation is dependent upon signals delivered through the antigen-specific T cell receptor and accessory receptors on the T cell. A primary costimulatory signal is delivered through the CD28 receptor after engagement of its ligands, B7-1 (CD80) or B7-2 (CD86). Engagement of CTLA-4 (CD152) by the same B7-1 or B7-2 ligands results in attenuation of T cells responses. Recently, molecular homologs of CD28 and CTLA-4 receptors and their B7-like ligands have been identified. ICOS is a CD28-like costimulatory receptor with a unique B7-like ligand. PD-1 is an inhibitory receptor, with two B7-like ligands. Additional members of B7 and CD28 gene families have been proposed. Integration of signals through this family of costimulatory and inhibitory receptors and their ligands is critical for activation of immune responses and tolerance. Understanding these pathways will allow development of new strategies for therapeutic intervention in immune-mediated diseases.

Full TextPDF

Chain of Reviews: Annual Reviews chapters connected to this topic

Most recent citing papers (via CrossRef)

Alcohol Exposure Impairs Myeloid Dendritic Cell Function in Rhesus Macaques
Alcoholism: Clinical and Experimental Research (2009)
Common Variable Immunodeficiency
Pediatric Research 65(Supplement):13R-19R (2009)
The role of costimulation in antibody deficiencies: ICOS and common variable immunodeficiency
Immunological Reviews 229(1):101-113 (2009)
Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells
Blood 113(13):2955-2964 (2009)
Suppressive Influences in the Immune Response to Cancer
Journal of Immunotherapy 32(1):1-11 (2009)
 
Series Home > Table of Contents > Abstract

Prev. Article | Next Article
Full-text HTML
View/Print PDF (265.4 KB)
Add to Favorites
Email link to a friend

Add to CiteULike Add to Connotea Add to del.icio.us

 
 
Quick Search
for 
Authors:
Beatriz M. Carreno and
Mary Collins
Keywords:
ICOS
PD-1
PD-L
T cell activation
tolerance

Users who read this review also read:

, ,
Annual Review of Immunology. Volume 23, Page 515-548, Apr 2005
Abstract | Full Text | PDF (179 KB) | Add to Favorites | Related 
, , ,
Annual Review of Immunology. Volume 26, Page 677-704, Apr 2008
Abstract | Full Text | PDF (396 KB) | Add to Favorites | Related 
, ,
Annual Review of Immunology. Volume 27, Page 591-619, Apr 2009
Abstract | Full Text | PDF (505 KB) | Add to Favorites | Related 
, , , , , , ,
Annual Review of Immunology. Volume 18, Page 767-811, Apr 2000
Abstract | Full Text | PDF (410 KB) | Add to Favorites | Related 

2009 Annual Reviews. All Rights Reserved.
  Technology Partner - Atypon Systems, Inc.